https://charityfund.eu/2021/04/24/avifavir-received-the-first-marketing-authorization-in-asia/2021-04-24T17:57:30+00:00https://charityfund.eu/2021/04/24/chemrar-group-of-companies-has-successfully-launched-the-worlds-first-drug-of-direct-antiviral-action-and-continues-to-develop-against-covid-19-and-its-consequences/2021-04-24T18:03:52+00:00https://charityfund.eu/2021/04/24/chromis-published-results-of-a-multi-center-open-label-post-marketing-clinical-study-in-940-covid-19-patients-confirming-efficacy-of-avifavir-at-croi2021/2021-04-24T18:08:40+00:00https://charityfund.eu/2021/04/24/the-international-expert-community-highlights-the-efficacy-and-safety-of-avifavir-in-covid-19-treatment/2021-04-24T18:17:53+00:00